Clofazimine Oxo Impurity

Clofazimine Oxo Impurity (CAS No. 90712-89-3, C₂₄H₁₅Cl₂N₃O, 432.31 g/mol) is a qualified pharmaceutical impurity standard used in impurity monitoring, forced degradation studies, method validation, and stability-indicating analytical methods for Clofazimine APIs and formulations. Supporting global regulatory requirements, including ICH, EMA, US FDA, USP, and EP guidelines, this impurity standard is extensively used in research and development, pharmaceutical quality control, and regulatory submissions. Manasa Life Sciences supplies this impurity with comprehensive documentation such as COA, HPLC purity reports, MS, NMR, IR characterization data, spectral analysis, and traceability records, ensuring confidence in analytical and regulatory applications.